Fundz

ZoeNCure Therapeutics secures INR 20 crore ($2.4M) seed funding led by Tyagi Family to advance next-generation ADC program for oncology.

PRIVATESep 03, 2026

Amount Raised

$2.4 Million

Round Type

Seed

BiotechnologyHealth CareTherapeutics

Investors

Shyambir TyagiManoj TyagiTyagi Family

Description

ZoeNCure Therapeutics, an oncology biotechnology company, announced the closing of an INR 20 Crore (approximately $2.4 Million USD) Seed financing round led by the Tyagi Family HNIs. This represents the second investment from the Tyagi Family, bringing total equity raised to INR 22.5 Crore. Proceeds will advance the company's lead ADC candidate toward Phase 1 clinical studies for hepatocellular carcinoma and gastrointestinal cancers, supporting preclinical studies, CMC scale-up, and regulatory submissions to CDSCO.

Quick answer

ZoeNCure Therapeutics Pvt. Ltd raised $2.4 Million in a Seed round, dated September 3, 2026. Investors: Shyambir Tyagi, Manoj Tyagi and Tyagi Family.

How much did ZoeNCure Therapeutics Pvt. Ltd raise?
ZoeNCure Therapeutics Pvt. Ltd raised $2.4 Million in a Seed round on September 3, 2026.
Who invested in ZoeNCure Therapeutics Pvt. Ltd?
Shyambir Tyagi, Manoj Tyagi and Tyagi Family are named as investors in this round.
What does ZoeNCure Therapeutics Pvt. Ltd do?
ZoeNCure Therapeutics is an oncology biotechnology company focused on developing high-potency targeted cancer therapies.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as ZoeNCure Therapeutics Pvt. Ltd that raised within 45 days of this round, from Fundz verified event records.

  • GenSight Biologics raised $1.1M (Post-IPO Equity) on October 16, 2026.
  • Estuary Biotherapeutics raised $93M (Series A) on October 16, 2026.
  • Acta Pharmaceuticals raised $24M (Seed) on October 15, 2026.
  • Float Bio raised $140K (Pre-Seed) on October 15, 2026.
  • Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
  • Os Therapies raised $7.2M on October 15, 2026.

Who to call at ZoeNCure Therapeutics Pvt. Ltd, and when

A new round usually means ZoeNCure Therapeutics Pvt. Ltd is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ZoeNCure Therapeutics Pvt. Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ZoeNCure Therapeutics Pvt. Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ZoeNCure Therapeutics Pvt. Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ZoeNCure Therapeutics Pvt. Ltd

About

ZoeNCure Therapeutics is an oncology biotechnology company focused on developing high-potency targeted cancer therapies. The company specializes in next-generation Antibody Drug Conjugate (ADC) programs with dual-payload precision oncology therapies designed to overcome treatment resistance. ZoeNCure is advancing its lead ADC candidate toward Phase 1 clinical studies for severe liver and gastrointestinal cancers, particularly hepatocellular carcinoma (HCC).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ZoeNCure Therapeutics Pvt. Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for ZoeNCure Therapeutics Pvt. Ltd's next move

See what Strategic adds

ZoeNCure Therapeutics Pvt. Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.